Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 44 | 44 | 44 | 44 | 44 |
| Gross Profit | 44 | 44 | 44 | 44 | 44 |
| Operating Expenses | 12,744 | 11,256 | 7,053 | 8,043 | 6,434 |
| Operating Income | -12,700 | -11,213 | -7,009 | -7,999 | -6,390 |
| Other Income | 1,074 | -2,770 | -3,676 | -5,806 | 212 |
| Pre-tax Income | -11,627 | -13,983 | -10,686 | -13,805 | -6,178 |
| Net Income Continuous | -11,627 | -13,983 | -10,686 | -13,805 | -6,178 |
| Minority Interests | 3 | -40 | -57 | -113 | -99 |
| Net Income | $-11,629 | $-13,943 | $-10,628 | $-13,692 | $-6,079 |
| EPS Basic Total Ops | -0.22 | -0.31 | -0.28 | -0.33 | -0.23 |
| EPS Basic Continuous Ops | -0.22 | -0.32 | -0.28 | -0.33 | -0.24 |
| EPS Diluted Total Ops | -0.22 | -0.31 | -0.28 | -0.33 | -0.23 |
| EPS Diluted Continuous Ops | -0.22 | -0.32 | -0.28 | -0.33 | -0.24 |
| EBITDA(a) | $-12,277 | $-10,576 | $-6,578 | $-7,554 | $-5,890 |